WO2011049538A3 - Pharmaceutical composition in dry powder form - Google Patents

Pharmaceutical composition in dry powder form Download PDF

Info

Publication number
WO2011049538A3
WO2011049538A3 PCT/TR2010/000207 TR2010000207W WO2011049538A3 WO 2011049538 A3 WO2011049538 A3 WO 2011049538A3 TR 2010000207 W TR2010000207 W TR 2010000207W WO 2011049538 A3 WO2011049538 A3 WO 2011049538A3
Authority
WO
WIPO (PCT)
Prior art keywords
dry powder
powder form
pharmaceutical composition
blister
agonists
Prior art date
Application number
PCT/TR2010/000207
Other languages
French (fr)
Other versions
WO2011049538A2 (en
Inventor
Bilgic Mahmut
Original Assignee
Bilgic Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bilgic Mahmut filed Critical Bilgic Mahmut
Publication of WO2011049538A2 publication Critical patent/WO2011049538A2/en
Publication of WO2011049538A3 publication Critical patent/WO2011049538A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Present invention relates to pharmaceutical compositions comprising β2-agonists and anticholinergic agents in dry powder form stored in a blister for use in the treatment of respiratory diseases.
PCT/TR2010/000207 2009-10-20 2010-10-20 Pharmaceutical composition in dry powder form WO2011049538A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2009/07915A TR200907915A2 (en) 2009-10-20 2009-10-20 Pharmaceutical composition in dry powder form.
TR2009/07915 2009-10-20

Publications (2)

Publication Number Publication Date
WO2011049538A2 WO2011049538A2 (en) 2011-04-28
WO2011049538A3 true WO2011049538A3 (en) 2011-11-03

Family

ID=43900868

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2010/000207 WO2011049538A2 (en) 2009-10-20 2010-10-20 Pharmaceutical composition in dry powder form

Country Status (2)

Country Link
TR (1) TR200907915A2 (en)
WO (1) WO2011049538A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102901821A (en) * 2012-09-27 2013-01-30 江苏维赛科技生物发展有限公司 Colloidal gold detection card for detecting adrenoreceptor stimulant and sample processing method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047200A1 (en) * 1999-02-08 2000-08-17 Novartis Ag Combinations of formoterol and a tiotropium salt
WO2001078739A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Medical combinations comprising tiotropium and fluticasone proprionate
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
WO2005053648A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Pre-metered dry powder inhaler for moisture-sensitive medicaments
WO2007012871A1 (en) * 2005-07-28 2007-02-01 Glaxo Group Limited Medicament dispenser
WO2011037551A2 (en) * 2009-09-23 2011-03-31 Mahmut Bilgic Carrying of a combination containing tiotropium in a blister strip

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534367A1 (en) 2002-07-25 2005-06-01 Glaxo Group Limited Medicament dispenser
DE102004026515A1 (en) 2004-05-19 2005-12-15 Deutsches Zentrum für Luft- und Raumfahrt e.V. Ceramic armor plate, tank system and method of making a ceramic armor plate
AR058290A1 (en) 2005-12-12 2008-01-30 Glaxo Group Ltd MEDICINAL DISPENSER

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047200A1 (en) * 1999-02-08 2000-08-17 Novartis Ag Combinations of formoterol and a tiotropium salt
WO2001078739A1 (en) * 2000-04-18 2001-10-25 Glaxo Group Limited Medical combinations comprising tiotropium and fluticasone proprionate
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
WO2005053648A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Pre-metered dry powder inhaler for moisture-sensitive medicaments
WO2007012871A1 (en) * 2005-07-28 2007-02-01 Glaxo Group Limited Medicament dispenser
WO2011037551A2 (en) * 2009-09-23 2011-03-31 Mahmut Bilgic Carrying of a combination containing tiotropium in a blister strip

Also Published As

Publication number Publication date
TR200907915A2 (en) 2011-05-23
WO2011049538A2 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
IL268756B (en) Piperazine-2,5-dione derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL215065A (en) Proline derivatives, process for their preparation, pharmaceutical compositions comprising said derivatives and use thereof for the preparation of medicaments
IL233677A (en) Substituted benzisoxazole aminopyrazolo-pyrimidine compounds, pharmaceutical compositions comprising them and use of the compounds for the manufacture of medicaments
IL223783B (en) Substituted 1-indole compound for use in the treatment of a disease or condition, a pharmaceutical composition comprising the compound and use of the compound for the preparation of a medicament
IL234166B (en) Isoindoline compounds, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments
IL216741A (en) 1,3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating diseases
IL223795A (en) Tetrahydro-pyrido-pyrimidine derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
IL206952A (en) Aminodihydrothiazine derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL222268A (en) Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
IL213019A (en) 1-aza-3-heteroaryl-azulene derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL213517A (en) Sulfonamide derivatives, pharmaceutical compositions comprising them and uses thereof in the manufacture of medicaments
EP2450046A4 (en) A medicinal composition for the treatment of bronchitis and preparation thereof
IL210997A (en) Compositions for the treatment of mrsa and uses thereof for the preparation of medicaments
IL212573A (en) Aryl methyl benzoquinazolinone compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL217572A (en) 1,3-propanedisulfonic acid esters, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments
IL199835A (en) Acid activated antimicrobial peptides, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
IL214309A (en) Substituted piperidines, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL209121A (en) Indazolyl derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of inflammatory diseases
IL233282A (en) Crystalline forms of 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine monohydrochloride, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
UA93709C2 (en) 12-imidazolyl-1-dodecanol and use thereof in the preparation of pharmaceutical compositions
IL203936A (en) Derivatives of 4-pyrimidinesulfamide, process for their preparation, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
IL223872A (en) Pyrazoloquinolines and intermediate compounds, process for their preparation, use thereof and medicaments and pharmaceutical compositions comprising them
EP2370068A4 (en) Methods and compositions for delivery of medicaments to the lungs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10774317

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10774317

Country of ref document: EP

Kind code of ref document: A2